<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35364800</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients.</ArticleTitle><Pagination><StartPage>3678</StartPage><EndPage>3689</EndPage><MedlinePgn>3678-3689</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-022-02789-4</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is known to be a progressive neurodegenerative disease that affects upper and lower motor neurons. Less than 10% of ALS patients are defined as familial ALS, and more than 90% are sporadic ALS (SALS). According to the genomic information described in existing databases, up to 98% of the human genome consists of non-coding sequences. Nearly 40% of long non-coding RNAs (lncRNAs) are specifically expressed in the brain. We believe that the discrepancy of lncRNAs expression plays a key role in neurodegenerative diseases. We screened 30 lncRNAs with altered expression from peripheral blood leukocytes of SALS patients by microarray and validated 13 of them in leukocytes of SALS, Parkinson's disease (PD) patients, and healthy controls (HC). We followed the bioinformatics to perform a functional enrichment analysis of co-expressed mRNAs, transcription factors, and lncRNAs for functional prediction. We identified that lnc-DYRYK2-7:1, lnc-ABCA12-3:1, and lnc-POTEM-4:7 show decreased expression in SALS patients, whereas in PD patients, they show increased expression or no change. In addition, expression of lnc-CNTN4-2:1 and lnc-NR3C2-8:1 was decreased in both SALS and PD patients. We found that XIST was only reduced in male patients with SALS and PD, and not in female patients with SALS but was elevated in PD by gender grouping. We also performed GO term enrichment and KEGG pathway analysis for lncRNAs showing differential expression in microarray. We discovered that a significant proportion of differential expressed lncRNAs were associated with various signaling pathways and transcription factors which are consistent with other clinical findings.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yujiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Dejiang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chunyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Xiaojing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yongping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Ruwei</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Huifang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0947-1151</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No.37, Guoxue Lane, Chengdu, Sichuan, 610041, China. hfshang2002@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81871000</GrantID><Agency>national natural science foundation of china</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">LncRNA</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35364800</ArticleId><ArticleId IdType="doi">10.1007/s12035-022-02789-4</ArticleId><ArticleId IdType="pii">10.1007/s12035-022-02789-4</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nat 539:197&#x2013;206</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Orrell RW (2016) Pathogenesis of amyotrophic lateral sclerosis. Br Med Bull 119:87&#x2013;97</Citation><ArticleIdList><ArticleId IdType="pubmed">27450455</ArticleId><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId></ArticleIdList></Reference><Reference><Citation>Krokidis MG, Vlamos P (2018) Transcriptomics in amyotrophic lateral sclerosis. Front Biosci Elite 10:103&#x2013;121</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/e811</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Leverenz JB, Bekris LM et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7:409&#x2013;416</Citation><ArticleIdList><ArticleId IdType="pubmed">18396105</ArticleId><ArticleId IdType="pmc">3546119</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Rademakers R, Neumann M (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9:995&#x2013;1007</Citation><ArticleIdList><ArticleId IdType="pubmed">20864052</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway MJ, Andersen PM, Russ C et al (2006) ANG mutations segregate with familial and &#x201c;sporadic&#x201d; amyotrophic lateral sclerosis. Nat Genet 38:411&#x2013;413</Citation><ArticleIdList><ArticleId IdType="pubmed">16501576</ArticleId><ArticleId IdType="doi">10.1038/ng1742</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pubmed">21944778</ArticleId><ArticleId IdType="pmc">3202986</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId></ArticleIdList></Reference><Reference><Citation>ENCODE Project Consortium (2012) An integrated encyclopedia of DNA elements in the human genome. Nat 489:57&#x2013;74</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes AQ, Nolasco S, Soares H (2013) Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci 14:16010&#x2013;16039</Citation><ArticleIdList><ArticleId IdType="pubmed">23912238</ArticleId><ArticleId IdType="pmc">3759897</ArticleId><ArticleId IdType="doi">10.3390/ijms140816010</ArticleId></ArticleIdList></Reference><Reference><Citation>Harries LW (2012) Long non-coding RNAs and human disease. Biochem Soc Trans 40:902&#x2013;906</Citation><ArticleIdList><ArticleId IdType="pubmed">22817756</ArticleId><ArticleId IdType="doi">10.1042/BST20120020</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams BD, Parsons C, Walker L et al (2017) Targeting noncoding RNAs in disease. J Clin Investig 127:761&#x2013;771</Citation><ArticleIdList><ArticleId IdType="pubmed">28248199</ArticleId><ArticleId IdType="pmc">5330746</ArticleId><ArticleId IdType="doi">10.1172/JCI84424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T (2004) Biogenesis of small nuclear RNPs. J Cell Sci 117:5949&#x2013;5951</Citation><ArticleIdList><ArticleId IdType="pubmed">15564372</ArticleId><ArticleId IdType="doi">10.1242/jcs.01487</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145&#x2013;166</Citation><ArticleIdList><ArticleId IdType="pubmed">22663078</ArticleId><ArticleId IdType="doi">10.1146/annurev-biochem-051410-092902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulitsky I, Bartel DP (2013) lincRNAs: genomics, evolution, and mechanisms. Cell 154:26&#x2013;46</Citation><ArticleIdList><ArticleId IdType="pubmed">23827673</ArticleId><ArticleId IdType="pmc">3924787</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2013.06.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Atianand MK, Caffrey DR, Fitzgerald KA (2017) Immunobiology of long noncoding RNAs. Annu Rev Immunol 35:177&#x2013;198</Citation><ArticleIdList><ArticleId IdType="pubmed">28125358</ArticleId><ArticleId IdType="pmc">6449690</ArticleId><ArticleId IdType="doi">10.1146/annurev-immunol-041015-055459</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien T, Johnson R, Bussotti G et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775&#x2013;1789</Citation><ArticleIdList><ArticleId IdType="pubmed">22955988</ArticleId><ArticleId IdType="pmc">3431493</ArticleId><ArticleId IdType="doi">10.1101/gr.132159.111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong J, Chuang SC, Bianchi R et al (2009) BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J Neurosci 29:9977&#x2013;9986</Citation><ArticleIdList><ArticleId IdType="pubmed">19675232</ArticleId><ArticleId IdType="pmc">2866649</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.3893-08.2009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Wang J, Liu Y, Zhou Y (2017) Mechanisms of long non-coding RNAs in the assembly and plasticity of neural circuitry. Front Neural Circuits 11:76</Citation><ArticleIdList><ArticleId IdType="pubmed">29109677</ArticleId><ArticleId IdType="pmc">5660110</ArticleId><ArticleId IdType="doi">10.3389/fncir.2017.00076</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Levey AI, Weintraub ST et al (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson&#x2019;s and Alzheimer&#x2019;s diseases. J Biol Chem 279:13256&#x2013;13264</Citation><ArticleIdList><ArticleId IdType="pubmed">14722078</ArticleId><ArticleId IdType="doi">10.1074/jbc.M314124200</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Xia ZA, Zhong B et al (2017) Distinct hippocampal expression profiles of long non-coding RNAs in an Alzheimer&#x2019;s disease model. Mol Neurobiol 54:4833&#x2013;4846</Citation><ArticleIdList><ArticleId IdType="pubmed">27501805</ArticleId><ArticleId IdType="doi">10.1007/s12035-016-0038-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan W, Chen ZY, Chen JQ, Chen HM (2018) LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson&#x2019;s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun 496:1019&#x2013;1024</Citation><ArticleIdList><ArticleId IdType="pubmed">29287722</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2017.12.149</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L, Liao Y-T, He J-C et al (2018) Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease. BMC Neurol 18:4</Citation><ArticleIdList><ArticleId IdType="pubmed">29316899</ArticleId><ArticleId IdType="pmc">5761117</ArticleId><ArticleId IdType="doi">10.1186/s12883-017-1008-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Boros FA, Maszlag-T&#xf6;r&#xf6;k R, V&#xe9;csei L, Kliv&#xe9;nyi P (2020) Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson&#x2019;s disease. Brain Res 1730:146672</Citation><ArticleIdList><ArticleId IdType="pubmed">31953211</ArticleId><ArticleId IdType="doi">10.1016/j.brainres.2020.146672</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y, Nakagawa S, Hirose T et al (2013) The long non-coding RNA nuclear-enriched abundant transcript 1&#x2013;2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol Brain 6:31</Citation><ArticleIdList><ArticleId IdType="pubmed">23835137</ArticleId><ArticleId IdType="pmc">3729541</ArticleId><ArticleId IdType="doi">10.1186/1756-6606-6-31</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheele C, Petrovic N, Faghihi MA et al (2007) The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function. BMC Genomics 8:74</Citation><ArticleIdList><ArticleId IdType="pubmed">17362513</ArticleId><ArticleId IdType="pmc">1831481</ArticleId><ArticleId IdType="doi">10.1186/1471-2164-8-74</ArticleId></ArticleIdList></Reference><Reference><Citation>Cellura E, Spataro R, Taiello AC, La Bella V (2012) Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 114:550&#x2013;554</Citation><ArticleIdList><ArticleId IdType="pubmed">22169158</ArticleId><ArticleId IdType="doi">10.1016/j.clineuro.2011.11.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Vejux A, Namsi A, Nury T et al (2018) Biomarkers of amyotrophic lateral sclerosis: current status and interest of oxysterols and phytosterols. Front Mol Neurosci 11:12</Citation><ArticleIdList><ArticleId IdType="pubmed">29445325</ArticleId><ArticleId IdType="pmc">5797798</ArticleId><ArticleId IdType="doi">10.3389/fnmol.2018.00012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S, Zucca S, Pandini C et al (2018) Long non-coding and coding RNAs characterization in peripheral blood mononuclear cells and spinal cord from amyotrophic lateral sclerosis patients. Sci Rep 8:2378</Citation><ArticleIdList><ArticleId IdType="pubmed">29402919</ArticleId><ArticleId IdType="pmc">5799454</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Chen X, Zheng Z et al (2015) Clinical features of amyotrophic lateral sclerosis in south-west China. Amyotroph Lateral Scler Frontotemporal Degener 16:512&#x2013;519</Citation><ArticleIdList><ArticleId IdType="pubmed">26203659</ArticleId><ArticleId IdType="doi">10.3109/21678421.2015.1069849</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="pubmed">21944779</ArticleId><ArticleId IdType="pmc">3200438</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lin Z, Chen X et al (2016) Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging 38:217.e15-217.e22</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.11.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-&#x394;&#x394;CT method. Methods 25:402&#x2013;408</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttman M, Amit I, Garber M et al (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nat 458:223&#x2013;227</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07672</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey JD (2002) A direct approach to false discovery rates. J R Stat Soc Series B Stat Methodol 64:479&#x2013;498</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1467-9868.00346</ArticleId></ArticleIdList></Reference><Reference><Citation>Babicki S, Arndt D, Marcu A et al (2016) Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res 44:W147&#x2013;W153</Citation><ArticleIdList><ArticleId IdType="pubmed">27190236</ArticleId><ArticleId IdType="pmc">4987948</ArticleId><ArticleId IdType="doi">10.1093/nar/gkw419</ArticleId></ArticleIdList></Reference><Reference><Citation>Volders PJ, Anckaert J, Verheggen K et al (2019) Lncipedia 5: towards a reference set of human long non-coding rnas. Nucleic Acids Res 47:D135&#x2013;D139</Citation><ArticleIdList><ArticleId IdType="pubmed">30371849</ArticleId><ArticleId IdType="doi">10.1093/nar/gky1031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang S, Zhang L, Guo J et al (2018) NONCODEV5: a comprehensive annotation database for long non-coding RNAs. Nucleic Acids Res 46:D308&#x2013;D314</Citation><ArticleIdList><ArticleId IdType="pubmed">29140524</ArticleId><ArticleId IdType="doi">10.1093/nar/gkx1107</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou M, Tang X, Tian F et al (2016) AnnoLnc: a web server for systematically annotating novel human lncRNAs. BMC Genomics 17:931</Citation><ArticleIdList><ArticleId IdType="pubmed">27852242</ArticleId><ArticleId IdType="pmc">5112684</ArticleId><ArticleId IdType="doi">10.1186/s12864-016-3287-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CJ, Hendrich BD, Rupert JL et al (1992) The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71:527&#x2013;542</Citation><ArticleIdList><ArticleId IdType="pubmed">1423611</ArticleId><ArticleId IdType="doi">10.1016/0092-8674(92)90520-M</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Macklin EA, Lee A et al (2014) Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener 15:453&#x2013;456</Citation><ArticleIdList><ArticleId IdType="pubmed">24981792</ArticleId><ArticleId IdType="pmc">4433003</ArticleId><ArticleId IdType="doi">10.3109/21678421.2014.903974</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14:544&#x2013;558</Citation><ArticleIdList><ArticleId IdType="pubmed">30120348</ArticleId><ArticleId IdType="pmc">6417666</ArticleId><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PP, Sun X, Xia G et al (2016) ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis. Ann Neurol 80:600&#x2013;615</Citation><ArticleIdList><ArticleId IdType="pubmed">27531668</ArticleId><ArticleId IdType="pmc">6555153</ArticleId><ArticleId IdType="doi">10.1002/ana.24761</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya N, Pandey V, Bhattacharyya M, Dey A (2021) Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: from novel biomarkers to promising therapeutic strategies. Asian J Pharm Sci. https://doi.org/10.1016/j.ajps.2021.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajps.2021.02.006</ArticleId><ArticleId IdType="pubmed">34849161</ArticleId><ArticleId IdType="pmc">8609388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S, Milani P, Sardone V et al (2012) From transcriptome to noncoding RNAs: implications in ALS mechanism. Neurol Res Int 2012:278725</Citation><ArticleIdList><ArticleId IdType="pubmed">22778949</ArticleId><ArticleId IdType="pmc">3385659</ArticleId><ArticleId IdType="doi">10.1155/2012/278725</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ (2010) The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). J Neurol Sci 288:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">19840884</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2009.09.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K-W, Chen J-A (2020) Functional roles of long non-coding RNAs in motor neuron development and disease. J Biomed Sci 27:38</Citation><ArticleIdList><ArticleId IdType="pubmed">32093746</ArticleId><ArticleId IdType="pmc">7041250</ArticleId><ArticleId IdType="doi">10.1186/s12929-020-00628-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson JN, Ensminger AW, Clemson CM et al (2007) A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 8:39</Citation><ArticleIdList><ArticleId IdType="pubmed">17270048</ArticleId><ArticleId IdType="pmc">1800850</ArticleId><ArticleId IdType="doi">10.1186/1471-2164-8-39</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N, Tie C, Yu B et al (2020) Identifying lncRNA-miRNA-mRNA networks to investigate Alzheimer&#x2019;s disease pathogenesis and therapy strategy. Aging 12:2897&#x2013;2920</Citation><ArticleIdList><ArticleId IdType="pubmed">32035423</ArticleId><ArticleId IdType="pmc">7041741</ArticleId><ArticleId IdType="doi">10.18632/aging.102785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Feng D, Li M et al (2019) Transcriptomic analysis of mRNA-lncRNA-miRNA interactions in hepatocellular carcinoma. Sci Rep 9:1&#x2013;12</Citation></Reference><Reference><Citation>Zhang Y, Li Y, Wang Q et al (2017) Identification of an incRNA-miRNA-mRNA interaction mechanism in breast cancer based on bioinformatic analysis. Mol Med Rep 16:5113&#x2013;5120</Citation><ArticleIdList><ArticleId IdType="pubmed">28849135</ArticleId><ArticleId IdType="pmc">5647044</ArticleId><ArticleId IdType="doi">10.3892/mmr.2017.7304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakil SJ, Abu-Elheiga LA (2009) Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50(Suppl):S138&#x2013;S143</Citation><ArticleIdList><ArticleId IdType="pubmed">19047759</ArticleId><ArticleId IdType="pmc">2674721</ArticleId><ArticleId IdType="doi">10.1194/jlr.R800079-JLR200</ArticleId></ArticleIdList></Reference><Reference><Citation>Turko IV, Marcondes S, Murad F (2001) Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 281:H2289&#x2013;H2294</Citation><ArticleIdList><ArticleId IdType="pubmed">11709394</ArticleId><ArticleId IdType="doi">10.1152/ajpheart.2001.281.6.H2289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotter DG, Schugar RC, Crawford PA (2013) Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol 304:H1060&#x2013;H1076</Citation><ArticleIdList><ArticleId IdType="pubmed">23396451</ArticleId><ArticleId IdType="pmc">3625904</ArticleId><ArticleId IdType="doi">10.1152/ajpheart.00646.2012</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukao T, Mitchell G, Sass JO, Hori T, Orii K, Aoyama Y (2014) Ketone body metabolism and its defects. J Inherit Metab Dis 37(4):541&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">24706027</ArticleId><ArticleId IdType="doi">10.1007/s10545-014-9704-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden SG, Ebshiana AA, Hye A et al (2017) Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: a nontargeted metabolomic study. PLoS Med 14:e1002266</Citation><ArticleIdList><ArticleId IdType="pubmed">28323825</ArticleId><ArticleId IdType="pmc">5360226</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1002266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogie JFJ, Haidar M, Kooij G, Hendriks JJA (2020) Fatty acid metabolism in the progression and resolution of CNS disorders. Adv Drug Deliv Rev 159:198&#x2013;213</Citation><ArticleIdList><ArticleId IdType="pubmed">31987838</ArticleId><ArticleId IdType="doi">10.1016/j.addr.2020.01.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal-Conde LD, Ramos-Acevedo R, Reyes-Hern&#xe1;ndez MA et al (2019) Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles. Front Neurosci 13:1399</Citation><ArticleIdList><ArticleId IdType="pubmed">32038126</ArticleId><ArticleId IdType="doi">10.3389/fnins.2019.01399</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayner SL, Morsch M, Molloy MP et al (2019) Using proteomics to identify ubiquitin ligase&#x2013;substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases. Cell Mol Life Sci 76:2499&#x2013;2510</Citation><ArticleIdList><ArticleId IdType="pubmed">30919022</ArticleId><ArticleId IdType="doi">10.1007/s00018-019-03082-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Noristani HN, Sabourin JC, Gerber YN et al (2015) Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS. Mol Neurodegener 10:34</Citation><ArticleIdList><ArticleId IdType="pubmed">26227626</ArticleId><ArticleId IdType="pmc">4521418</ArticleId><ArticleId IdType="doi">10.1186/s13024-015-0023-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabili MN, Dunagin MC, McClanahan PD et al (2015) Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol 16:20</Citation><ArticleIdList><ArticleId IdType="pubmed">25630241</ArticleId><ArticleId IdType="pmc">4369099</ArticleId><ArticleId IdType="doi">10.1186/s13059-015-0586-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemson CM, McNeil JA, Willard HF, Lawrence JB (1996) XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. J Cell Biol 132:259&#x2013;275</Citation><ArticleIdList><ArticleId IdType="pubmed">8636206</ArticleId><ArticleId IdType="doi">10.1083/jcb.132.3.259</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh CA, Chen CK, Chow A et al (2015) The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature 521:232&#x2013;236</Citation><ArticleIdList><ArticleId IdType="pubmed">25915022</ArticleId><ArticleId IdType="pmc">4516396</ArticleId><ArticleId IdType="doi">10.1038/nature14443</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Ellingson MK, Wong P et al (2020) Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588:315&#x2013;320</Citation><ArticleIdList><ArticleId IdType="pubmed">32846427</ArticleId><ArticleId IdType="pmc">7725931</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerase A, Armaos A, Neumayer C et al (2019) Phase separation drives X-chromosome inactivation: a hypothesis. Nat Struct Mol Biol 26:331&#x2013;334</Citation><ArticleIdList><ArticleId IdType="pubmed">31061525</ArticleId><ArticleId IdType="doi">10.1038/s41594-019-0223-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallen AN, Zhou XB, Xu J et al (2013) The imprinted H19 LncRNA antagonizes Let-7 microRNAs. Mol Cell 52:101&#x2013;112</Citation><ArticleIdList><ArticleId IdType="pubmed">24055342</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2013.08.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xu Z, Jiang J et al (2013) Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 25:69&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">23541921</ArticleId><ArticleId IdType="doi">10.1016/j.devcel.2013.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505:344&#x2013;352</Citation><ArticleIdList><ArticleId IdType="pubmed">24429633</ArticleId><ArticleId IdType="pmc">4113481</ArticleId><ArticleId IdType="doi">10.1038/nature12986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>